摘要
目的:探讨化纤方中药制剂对胸部肿瘤放疗所致肺放射损伤的预防作用。方法:145例胸部肿瘤患者随机分为试验组69例,对照组76例,均接受胸部肿瘤常规放疗。试验组病例在放疗同时应用化纤方中药制剂治疗至放疗结束,对照组患者则仅接受放疗治疗。结果:两组放疗后放射性肺炎及放射性肺纤维化的发生率分别为38.1%、11.6%和27.6%、7.2%,两组比较差异有统计学意义(P<0.05)。结论:化纤方中药制剂能够降低胸部肿瘤放疗所致放射性肺炎及肺纤维化的发生率,对肺放射损伤有明显的预防作用。
Objective ： To explore the efect of the prevention for radiation pulmonary injury caused by radiotherapy for chest tumors with melt fibrosis traditional Chinese medicine（TCM）. Methods ：148 cases of chest tumors were treated by chest radical radiotherapy. 70 patients of experiment group were taken orally by TCM melt fibrosis medicine till the radiotherapy end. 78 patients of control group were taken orally by placebo. Results ： The incidence rate of radiation pneumonia and pulmonary fibrosis in experiment group and control group was 38.1%, 11.6%, and 27.6%, 7.2% , respectively. The difference was significant between two groups P 〈0.05. Conclusion ：TCM melt fibrosis medicine,it can prevent significantly the occurrence of radiation pulmonary injuries of chest tumors. It could reduce the incidence rate of radiation pneumonia and pulmonary fibrosis.
出处
《辽宁中医杂志》
CAS
北大核心
2008年第2期225-226,共2页
Liaoning Journal of Traditional Chinese Medicine
关键词
化纤方中药制剂
肺放射损伤
胸部肿瘤
放疗
melt fibrosis traditional Chinese medicine
radiation pulmonary injuries
chest tumors
radiotherapy
